Curcumin as a putative antidepressant

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2015-02-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14737175.2015.1008457PMID 25644944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of the Efficacy of Adjunctive Therapy with Bioavailability‐Boosted Curcuminoids in Major Depressive Disorder

  2015cited by this paper
• Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress.

  2014cited by this paper
• Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats.

  2014cited by this paper
• Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.

  2014influential reference
• Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial

  2014influential reference
• Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice.

  2013cited by this paper
• Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action.

  2013cited by this paper
• Clinical utility of curcumin extract.

  2013influential reference
• Moderators of outcome in late-life depression: a patient-level meta-analysis.

  2013cited by this paper
• Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study

  2013influential reference
• Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice.

  2013cited by this paper
• Suppression of Neuroinflammatory and Apoptotic Signaling Cascade by Curcumin Alone and in Combination with Piperine in Rat Model of Olfactory Bulbectomy Induced Depression

  2013cited by this paper
• Scopolamine as an antidepressant.

  2013cited by this paper
• Free and nanoencapsulated curcumin prevents cigarette smoke-induced cognitive impairment and redox imbalance.

  2013cited by this paper
• Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection

  2012influential reference
• A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.

  2012cited by this paper
• Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.

  2012cited by this paper
• Frontiers in Research: Herbal Bioactive Molecules: The Hidden Jewels for Drug Development Discovery of curcumin, a component of golden spice, and its miraculous biological activities

  2012influential reference
• The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.

  2012cited by this paper
• Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

  2012cited by this paper
• Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression

  2012cited by this paper
• Neuroplastic changes in depression: a role for the immune system.

  2012cited by this paper
• Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects

  2012cited by this paper
• Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

  2012influential reference
• Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences.

  2011cited by this paper
• Brain and Spinal Cord Interaction

  2011cited by this paper
• Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats.

  2011influential reference
• Role of nuclear factor-κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents

  2011influential reference
• The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.

  2011cited by this paper
• Comment on treatment of psychiatric illness in patients with mitochondrial disease.

  2011cited by this paper
• Differential distribution of intravenous curcumin formulations in the rat brain.

  2011cited by this paper
• Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property.

  2011cited by this paper
• Do we need more than one antidepressant for patients with major depressive disorder?

  2011cited by this paper
• Nitric oxide and major depression.

  2011cited by this paper
• Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation.

  2011cited by this paper
• Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.

  2011cited by this paper
• Treatment-resistant depression: prevalence, risk factors, and treatment strategies.

  2011cited by this paper
• Curcumin prevents corticosterone‐induced neurotoxicity and abnormalities of neuroplasticity via 5‐HT receptor pathway

  2011cited by this paper
• Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity.

  2011cited by this paper
• A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

  2011cited by this paper
• Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression

  2011cited by this paper
• A Curcumin Derivative, 2,6-Bis(2,5-dimethoxybenzylidene)-cyclohexanone (BDMC33) Attenuates Prostaglandin E2 Synthesis via Selective Suppression of Cyclooxygenase-2 in IFN-γ/LPS-Stimulated Macrophages

  2011cited by this paper
• Gene–environment interactions: early life stress and risk for depressive and anxiety disorders

  2011cited by this paper
• Innovative preparation of curcumin for improved oral bioavailability.

  2011cited by this paper
• Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism.

  2011cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis.

  2010cited by this paper
• GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice.

  2010cited by this paper
• Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation

  2010cited by this paper
• Neuroprotective effects of naturally occurring polyphenols on quinolinic acid‐induced excitotoxicity in human neurons

  2010cited by this paper
• Curcumin Inhibits the proteinase-activated receptor-2-triggered prostaglandin E2 production by suppressing cyclooxygenase-2 upregulation and Akt-dependent activation of nuclear factor-κB in human lung epithelial cells.

  2010cited by this paper
• Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.

  2009cited by this paper
• Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress.

  2009cited by this paper
• Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats.

  2009cited by this paper
• Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression

  2009cited by this paper
• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

  2009cited by this paper
• Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

  2009cited by this paper
• Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

  2009cited by this paper
• Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

  2009cited by this paper
• Curcumin Suppresses the Induction of Indoleamine 2,3-Dioxygenase by Blocking the Janus-activated Kinase-Protein Kinase Cδ-STAT1 Signaling Pathway in Interferon-γ-stimulated Murine Dendritic Cells*

  2009cited by this paper
• Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.

  2008cited by this paper
• Curcumin inhibits the increase of glutamate, hydroxyl radicals and PGE2 in the hypothalamus and reduces fever during LPS-induced systemic inflammation in rabbits.

  2008cited by this paper
• Antidepressant activity of curcumin: involvement of serotonin and dopamine system

  2008cited by this paper
• Mitochondrial involvement in psychiatric disorders

  2008cited by this paper
• Interaction between BDNF and Serotonin: Role in Mood Disorders

  2008influential reference
• Triple Reuptake Inhibitors: A Premise and Promise

  2008cited by this paper
• The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.

  2008cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants.

  2008cited by this paper
• Possible nitric oxide modulation in protective effect of (Curcuma longa, Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice.

  2008cited by this paper
• A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95®CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin

  2008cited by this paper
• Does minocycline have antidepressant effect?

  2008cited by this paper
• Inflammation, Glutamate, and Glia in Depression: A Literature Review

  2008cited by this paper
• Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

  2008cited by this paper
• Antioxidant and radical scavenging properties of curcumin.

  2008cited by this paper
• Multi-targeted therapy by curcumin: how spicy is it?

  2008cited by this paper
• Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

  2008cited by this paper
• Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products.

  2007cited by this paper
• Mitochondrial dysfunction and molecular pathways of disease.

  2007cited by this paper
• Which antidepressants have demonstrated superior efficacy? A review of the evidence

  2007cited by this paper
• Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test.

  2007cited by this paper
• Bioavailability of curcumin: problems and promises.

  2007cited by this paper
• Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats.

  2007cited by this paper
• Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects

  2006cited by this paper
• Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.

  2006cited by this paper
• Increased Plasma Nitric Oxide Metabolites in Suicide Attempters

  2006cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study

  2005cited by this paper
• Prognosis of depression in old age compared to middle age: a systematic review of comparative studies.

  2005cited by this paper
• Low plasma vitamin E levels in major depression: diet or disease?

  2005cited by this paper
• The olfactory bulbectomised rat as a model of depression.

  2005cited by this paper
• Of interest

  2005cited by this paper
• Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.

  2005cited by this paper
• Phase I Clinical Trial of Oral Curcumin

  2004cited by this paper
• Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase

  2004cited by this paper
• Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase.

  2004cited by this paper
• Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons.

  2004cited by this paper
• Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance

  2004cited by this paper
• Forced swimming test in mice: a review of antidepressant activity

  2004cited by this paper
• Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

  2001cited by this paper

• Monoamine signaling and neuroinflammation: mechanistic connections and implications for neuropsychiatric disorders

  2025cites this paper
• Design and Synthesis of Benzylidene Derivatives of Curcumin, and Evaluation of Its Antioxidant and Chelating Activities

  2025cites this paper
• Role of isolated compounds from spices and herbs in natural medicinal care or therapy-A review

  2024cites this paper
• New curcumin-loaded nanocapsules as a therapeutic alternative in an amnesia model

  2024cites this paper
• Preliminary Investigation Into the Antidepressant Effects of a Novel Curcumin Analogue (CACN136) In Vitro and In Vivo

  2024cites this paper
• The Effect of Adding Curcumin to Sertraline in the Treatment of Severe Major Depressive Disorder: A Randomized, Double-Blind Clinical Trial

  2023cites this paper
• The Golden Spice for Life: Turmeric with the Pharmacological Benefits of Curcuminoids Components, including Curcumin, Bisdemethoxycurcumin, and Demethoxycurcumin.

  2023cites this paper
• Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction

  2023cites this paper
• Antidepressant Activities of Synthesized Benzodiazepine Analogues in Mice

  2023cites this paper
• Antidepressant-like activity of oroxylin A in mice models of depression: A behavioral and neurobiological characterization

  2022cites this paper
• Brain structure and synaptic related protein expression alterations after antidepressant treatment in a Wistar-Kyoto rat model of depression.

  2022cites this paper
• Investigation of Antistress and Antidepressant Activities of Synthetic Curcumin Analogues: Behavioral and Biomarker Approach

  2022cites this paper
• Chinese Pharmacopoeia Revisited: A Review of Anti-Depression Herbal Sources

  2021cites this paper
• Xanthoceraside administration produces significant antidepressant effects in mice through activation of the hippocampal BDNF signaling pathway.

  2021cites this paper
• The pharmacological basis of the curcumin nutraceutical uses: an update

  2021cites this paper
• Structure-Activity Relationship and Antimicrobial Evaluation of N-Phenylpyrazole Curcumin Derivatives

  2020cites this paper
• Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways

  2020cites this paper
• Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice.

  2020cites this paper
• Curcumin in antidepressant treatments: An overview of potential mechanisms, pre‐clinical/clinical trials and ongoing challenges

  2020cites this paper
• Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma

  2020cites this paper
• The role of neuroinflammation on pathogenesis of affective disorders

  2020cites this paper
• Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review

  2020cites this paper
• Standardized turmeric and curcumin

  2019cites this paper
• Nutraceuticals in Veterinary Medicine

  2019cites this paper
• Recent Updates in Curcumin Pyrazole and Isoxazole Derivatives: Synthesis and Biological Application

  2019cites this paper
• Obvious anxiogenic-like effects of subchronic copper intoxication in rats, outcomes on spatial learning and memory and neuromodulatory potential of curcumin.

  2019cites this paper
• Herbs and Spices- Biomarkers of Intake Based on Human Intervention Studies – A Systematic Review

  2019cites this paper
• [Possible Treatment of Neuropsychiatric Disorders by Promotion of Neuronal Differentiation through Organic Cation Transporters].

  2019cites this paper
• Novel targets for parkinsonism-depression comorbidity.

  2019cites this paper
• Role of Inflammation in Psychiatric Disorders.

  2019cites this paper
• Use of Curcumin in Eye Pathologies: A Review

  2019cites this paper
• Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin

  2018cites this paper
• Total saponins from the leaves of Panax notoginseng inhibit depression on mouse chronic unpredictable mild stress model by regulating circRNA expression

  2018cites this paper
• Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial.

  2017cites this paper
• Impact of a Detox Diet paradigm in Weight Management

  2017cites this paper
• Natural Polyphenols and Terpenoids for Depression Treatment: Current Status

  2017cites this paper
• The True Nature of Curcumin’s Polypharmacology

  2017cites this paper
• The True Nature of Curcuminâs Polypharmacology

  2017cites this paper
• Ginsenoside Rg3 exerts anti-depressive effect on an NMDA-treated cell model and a chronic mild stress animal model.

  2017cites this paper
• Antidepressant-like effects of ginsenosides: A comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, compound K, and 20(S)-protopanaxadiol in mice models of despair.

  2016cites this paper
• Duality of Antidepressants and Neuroprotectants

  2016cites this paper
• Effects of turmeric curcuminoids and metformin against central sensitivity to pain in mice

  2016cites this paper
• Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings.

  2016cites this paper
• Comparative Study on the Activity of Agomelatine and/or Curcumin against Development of Depression in Rats

  2016cites this paper